Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin's disease.
Indian J Pediatr
;
2006 May; 73(5): 437-8
Artículo
en Inglés
| IMSEAR
| ID: sea-81149
ABSTRACT
Hodgkin's disease survivors are at an increased risk of developing second malignant neoplasms including secondary bone tumors. Common secondary bone tumors are osteogenic sarcoma and fibrosarcoma. Secondary primitive neuroectodermal tumor is extremely rare in this group. We present below, a rare case of secondary PNET in an 8-year-old child with Hodgkin's disease which developed unusually early outside the radiation portal and discuss potential factors responsible for its causation.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Vinblastina
/
Bleomicina
/
Neoplasias Óseas
/
Humanos
/
Masculino
/
Enfermedad de Hodgkin
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Doxorrubicina
/
Niño
/
Neoplasias Primarias Secundarias
Idioma:
Inglés
Revista:
Indian J Pediatr
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS